Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT03761394

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03761394
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03761394. Randomized; single masking; primary purpose diagnostic. Start 2019-09-03 (actual); primary completion 2021-09-20 (actual). Results posted on 2023-11-18.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke
Condition
Stroke
Intervention (Device)
Testing Devices
Intervention (Device)
Cardea Solo by Cardiac Insight
Intervention (Device)
Kardia Mobile by AliveCor
Lead sponsor
University of Massachusetts, Worcester (class: other)
Collaborator
University of Connecticut (class: other)
Collaborator
Northeastern University (class: other)
Collaborator
Brigham and Women's Hospital (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct03761394
Content hash
67d412bdfa4383045db385bd62f0f729e379122ef4e13095fdfb4a6d3040def0